American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, announced today that it will release its first quarter 2026 financial results before the market opens on May 14, 2026. The company will hold a conference call the same day at 12:00 pm ET to discuss the results.
To participate in the call, domestic callers can dial 1-844-413-3972 and international callers can dial 1-412-317-5776 at least 10 minutes prior to the start time and ask to join the American Shared Hospital Services call. A simultaneous webcast will be available through the company's website at www.ashs.com or directly via this link.
A replay of the call will be available from May 14 through May 21, 2026, by dialing 1-855-669-9658 or 1-412-317-0088 with access code 6753554. The replay will also be accessible on the company's website.
American Shared Hospital Services provides turnkey solutions to cancer treatment centers, health systems, and cancer networks in North and South America. The company works with partners to develop and grow their cancer service lines, offering integrated cancer care in local community settings. Under health system partnerships, the company and its partners share capital investment costs and profitability based on ownership interests.
This earnings announcement is significant for investors and industry observers as it provides insights into the company's financial health and growth trajectory in the cancer treatment equipment and services market. The company has been expanding its Gamma Knife, proton therapy, and advanced radiation therapy businesses, which are capital-intensive and subject to regulatory and reimbursement risks. The call will likely address these factors and provide guidance on future performance.
The company's forward-looking statements in the press release note risks including economic conditions, compliance with debt covenants, variability of financial results, changes in CMS reimbursement rates, and the timing and financing of its business operations. Investors will be keen to hear management's outlook on these issues during the call.
